RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference )
Also on site :